Skip To Main Content

Transplantační medicína

Nejnovější trendy

Prozkoumejte nejčtenější články a videa na Campus Sanofi

Seřadit

Patient morbidity and mortality in BP

Many factors, including older age and multimorbidity, are associated with mortality in bullous pemphigoid. Read this article to find out more

What is Bullous Pemphigoid

The heterogeneous presentation of bullous pemphigoid may shed light on why patients are underdiagnosed. Read the article to learn more

ATAR Çalışması: Kombinasyon Tedavisinde 24 Saatlik Kan Basıncı Kontrolü

Wykrycie wirusa polio typu 2 pochodzącego ze szczepionki w próbkach ścieków w Polsce

Poliomyelitis pozostaje istotnym problemem zdrowia publicznego, nawet w krajach od dawna uznawanych za wolne od polio.

Plano de Exercício Sanofi e APCL ultrapassa 200 participações

BR1DGE: Eleve o seu conhecimento em DT1 para o próximo nível

Vidéo sur ASMD en 4 min

Niemann-Pick: Comprendre le déficit en sphingomyélinase acide en 4 minutes

BRIGHT publication

BRIGHT publication

The Bright study demonstrated similar efficacy and safety of Toujeo® (Glargine 300 U/ml) compared to degludec 100 U/ml in type 2 diabetes patients who had not previously received basal insulin1.

BRIGHT publication

The Bright study demonstrated similar efficacy and safety of Toujeo® (Glargine 300) compared to degludec (insulin degludec) in type 2 diabetes patients who had not previously received basal insulin1.

ATS 2025 Scientific Highlights

May 17–21, 2025; San Francisco, California, US

ATS 2025 Scientific Highlights

May 17–21, 2025; San Francisco, California, US